| 2025-12-24 |
复牌提示：
2025-12-24 10:09:06 停牌，复牌日期 2025-12-24 10:14:06
|
| 2025-11-13 |
详情>>
股本变动：
变动后总股本7090.05万股
|
| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.47美元,归母净利润-8980.1万美元,同比去年增长28.42%
|
| 2025-11-13 |
财报披露：
美东时间 2025-11-13 盘后发布财报
|
| 2025-10-13 |
详情>>
内部人交易：
Demopulos Gregory A MD股份减少600000.00股
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-1.01美元,归母净利润-5888.4万美元,同比去年增长36.84%
|
| 2025-05-30 |
股东大会：
将于2025-06-27召开股东大会
会议内容 ▼▲
- 1.To elect the two Class I director nominees named in this proxy statement to the board of directors, each to serve until the 2028 Annual Meeting of Shareholders;
2.To approve an advisory resolution on executive compensation;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
4.To transact such other business as may properly come before the 2025 Annual Meeting or any adjournment or postponement thereof.
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.58美元,归母净利润-3346万美元,同比去年增长10.02%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-2.7美元,归母净利润-1.57亿美元,同比去年增长-33.11%
|
| 2025-03-31 |
详情>>
业绩披露：
2022年年报每股收益0.76美元,归母净利润4741.70万美元,同比去年增长-75.59%
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.15美元,归母净利润-1.25亿美元,同比去年增长-15.37%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益-1.13美元,归母净利润-7099.5万美元,同比去年增长-11.17%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-1.6美元,归母净利润-9322.5万美元,同比去年增长-31.31%
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.63美元,归母净利润-3718.4万美元,同比去年增长-10.34%
|
| 2024-04-29 |
股东大会：
将于2024-06-06召开股东大会
会议内容 ▼▲
- 1.To elect the three Class III director nominees named in this proxy statement to the board of directors, each to serve until the 2027 Annual Meeting of Shareholders;
2.To approve an advisory resolution on executive compensation;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
4.To transact such other business as may properly come before the 2024 Annual Meeting or any adjournment or postponement thereof.
|
| 2024-04-01 |
详情>>
业绩披露：
2023年年报每股收益-1.88美元,归母净利润-1.18亿美元,同比去年增长-348.46%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.73美元,归母净利润-1.09亿美元,同比去年增长-33.73%
|
| 2023-05-17 |
股东大会：
将于2023-06-23召开股东大会
会议内容 ▼▲
- 1.Election of the three Class II directors (Proposal 1)
2.Approval of an advisory resolution on executive compensation (Proposal 2)
3.Advisory vote on the frequency of future advisory votes on executive compensation (Proposal 3)
4.Amendment to the Omeros Corporation 2017 Omnibus Incentive Compensation Plan (Proposal 4)
5.Ratification of the Appointment of Independent Registered Public Accounting Firm (Proposal 5)
|
| 2022-05-02 |
股东大会：
将于2022-06-17召开股东大会
会议内容 ▼▲
- 1.to elect the two Class I director nominees named in this proxy statement to the board of directors, each to serve until the 2025 Annual Meeting of Shareholders;
2.to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.to transact such other business as may properly come before the 2022 Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-11召开股东大会
会议内容 ▼▲
- 1.to elect the three Class III director nominees named in this proxy statement to the board of directors, each to serve until the 2024 Annual Meeting of Shareholders;
2.to approve an amendment to the Omeros Corporation 2017 Omnibus Incentive Compensation Plan to increase the number of authorized shares;
3.to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
4.to transact such other business as may properly come before the 2021 Annual Meeting or any adjournment or postponement thereof.
|
| 2020-04-29 |
股东大会：
将于2020-06-05召开股东大会
会议内容 ▼▲
- 1.to elect the three Class II director nominees named in this proxy statement to the board of directors, each to serve until the 2023 Annual Meeting of Shareholders;
2.to approve an advisory resolution on executive compensation;
3.to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
4.to transact such other business as may properly come before the 2020 Annual Meeting or any adjournment or postponement thereof.
|
| 2019-04-29 |
股东大会：
将于2019-06-07召开股东大会
会议内容 ▼▲
- 1.to elect the three Class I director nominees named in this proxy statement to the board of directors, each to serve until the 2022 Annual Meeting of Shareholders, and to elect the one Class III director nominee named in this proxy statement to the board of directors to serve until the 2021 Annual Meeting of Shareholders;
2.to approve an amendment and restatement of the Omeros Corporation 2017 Omnibus Incentive Compensation Plan;
3.to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
4.to transact such other business as may properly come before the 2019 Annual Meeting or any adjournment or postponement thereof.
|
| 2018-04-30 |
股东大会：
将于2018-06-15召开股东大会
会议内容 ▼▲
- (1)to elect the two Class III director nominees named in this proxy statement to the board of directors, each to serve until the 2021 Annual Meeting of Shareholders;
(2)to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
(3)to transact such other business as may properly come before the 2018 Annual Meeting or any adjournment or postponement thereof.
|
| 2017-04-25 |
股东大会：
将于2017-06-16召开股东大会
会议内容 ▼▲
- 1.to elect the two Class II director nominees named in this proxy statement to the board of directors, each to serve until the 2020 Annual Meeting of Shareholders;
2.to approve an advisory resolution on executive compensation;
3.to conduct an advisory vote on the frequency of future advisory votes on executive compensation;
4.to approve the Omeros Corporation 2017 Omnibus Incentive Compensation Plan;
5.to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
6.to transact such other business as may properly come before the 2017 Annual Meeting or any adjournment or postponement thereof.
|
| 2016-04-22 |
股东大会：
将于2016-06-09召开股东大会
会议内容 ▼▲
- 1.to elect the three Class I director nominees named in this proxy statement to the board of directors, each to serve until the 2019 Annual Meeting of Shareholders;
2.to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
3.to transact such other business as may properly come before the 2016 Annual Meeting or any adjournment or postponement of the 2016 Annual Meeting.
|